Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
TRB-051 by Trex Bio for Inflammation: Likelihood of Approval
TRB-051 is under clinical development by Trex Bio and currently in Phase I for Inflammation. According to GlobalData, Phase I...
Data Insights
TRB-051 by Trex Bio for Autoimmune Disorders: Likelihood of Approval
TRB-051 is under clinical development by Trex Bio and currently in Phase I for Autoimmune Disorders. According to GlobalData, Phase...